These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22511516)

  • 1. Derivation of a brief measure of agitation and aggression in Alzheimer's disease.
    Dennehy EB; Kahle-Wrobleski K; Sarsour K; Milton DR
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):182-9. PubMed ID: 22511516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction.
    Senanarong V; Cummings JL; Fairbanks L; Mega M; Masterman DM; O'Connor SM; Strickland TL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):14-20. PubMed ID: 14560060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.
    Matsumoto N; Ikeda M; Fukuhara R; Shinagawa S; Ishikawa T; Mori T; Toyota Y; Matsumoto T; Adachi H; Hirono N; Tanabe H
    Dement Geriatr Cogn Disord; 2007; 23(4):219-24. PubMed ID: 17299264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].
    Hirono N; Tsukamoto N; Inoue M; Moriwaki Y; Mori E
    No To Shinkei; 2002 Sep; 54(9):812-8. PubMed ID: 12428367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer's disease subjects.
    White HK; McConnell ES; Bales CW; Kuchibhatla M
    J Am Med Dir Assoc; 2004; 5(2):89-97. PubMed ID: 14984619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: symptom clusters.
    Garre-Olmo J; López-Pousa S; Vilalta-Franch J; de Gracia Blanco M; Vilarrasa AB
    J Alzheimers Dis; 2010; 22(4):1157-67. PubMed ID: 20930289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity and responsiveness to change of clinically derived MDS scales in Alzheimer disease outcomes research.
    Smart KA; Herrmann N; Lanctôt KL
    J Geriatr Psychiatry Neurol; 2011 Jun; 24(2):67-72. PubMed ID: 21460341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity and reliability of the newly translated Hellenic Neuropsychiatric Inventory (H-NPI) applied to Greek outpatients with Alzheimer's disease: a study of disturbing behaviors among referrals to a memory clinic.
    Politis AM; Mayer LS; Passa M; Maillis A; Lyketsos CG
    Int J Geriatr Psychiatry; 2004 Mar; 19(3):203-8. PubMed ID: 15027034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of psychiatric function disorders in psychogeriatric patients at referral to nursing home care--the relation to cognition, activities of daily living and general details.
    Bakker TJ; Duivenvoorden HJ; van der Lee J; Trijsburg RW
    Dement Geriatr Cogn Disord; 2005; 20(4):215-24. PubMed ID: 16088137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease.
    Herrmann N; Gauthier S; Boneva N; Lemming OM;
    Int Psychogeriatr; 2013 Jun; 25(6):919-27. PubMed ID: 23472619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in nursing burden following memantine for agitation and aggression in long-term care residents with moderate to severe Alzheimer's disease: an open-label pilot study.
    Herrmann N; Cappell J; Eryavec GM; Lanctôt KL
    CNS Drugs; 2011 May; 25(5):425-33. PubMed ID: 21476613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric profiles of patients with Alzheimer's disease and vascular dementia in Taiwan.
    Hsieh CJ; Chang CC; Lin CC
    Int J Geriatr Psychiatry; 2009 Jun; 24(6):570-7. PubMed ID: 19051223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the Japanese version of the Dysexecutive Questionnaire (DEX) in Alzheimer's disease: validation of a behavioral rating scale to assess dysexecutive symptoms in Japanese patients with Alzheimer's disease.
    Shinagawa Y; Nakaaki S; Hongo J; Murata Y; Sato J; Matsui T; Tatsumi H; Akechi T; Furukawa TA
    Int J Geriatr Psychiatry; 2007 Oct; 22(10):951-6. PubMed ID: 17299806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for neuropsychiatric symptoms in dementia: the Cache County Study.
    Steinberg M; Corcoran C; Tschanz JT; Huber C; Welsh-Bohmer K; Norton MC; Zandi P; Breitner JC; Steffens DC; Lyketsos CG
    Int J Geriatr Psychiatry; 2006 Sep; 21(9):824-30. PubMed ID: 16955439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and validity of the Japanese version of the Agitated Behaviour in Dementia Scale in Alzheimer's disease: three dimensions of agitated behaviour in dementia.
    Torii K; Nakaaki S; Banno K; Murata Y; Sato J; Tatsumi H; Yamanaka K; Narumoto J; Mimura M; Akechi T; Furukawa TA
    Psychogeriatrics; 2011 Dec; 11(4):212-20. PubMed ID: 22151240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reliability and validity of the Norwegian version of the Neuropsychiatric Inventory, nursing home version (NPI-NH).
    Selbaek G; Kirkevold O; Sommer OH; Engedal K
    Int Psychogeriatr; 2008 Apr; 20(2):375-82. PubMed ID: 17559707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Icelandic version of the Neuropsychiatric Inventory with Caregiver Distress (NPI-D).
    Davidsdottir SR; Snaedal J; Karlsdottir G; Atladottir I; Hannesdottir K
    Nord J Psychiatry; 2012 Feb; 66(1):26-32. PubMed ID: 21770826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.